0000899243-19-027114.txt : 20191112
0000899243-19-027114.hdr.sgml : 20191112
20191112161524
ACCESSION NUMBER: 0000899243-19-027114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191112
FILED AS OF DATE: 20191112
DATE AS OF CHANGE: 20191112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beardsley Robert A
CENTRAL INDEX KEY: 0001310845
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 191209590
MAIL ADDRESS:
STREET 1: 6935 WATERMAN AVENUE
CITY: UNIVERSITY CITY
STATE: MO
ZIP: 63130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 LINDENWOOD DRIVE
STREET 2: SUITE 405
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 101 LINDENWOOD DRIVE
STREET 2: SUITE 405
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-12
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001310845
Beardsley Robert A
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Common Stock
2019-11-12
4
C
0
15361
A
68191
D
Series A Preferred Stock
2019-11-12
4
C
0
68907
D
Common Stock
13627
0
D
Series B Preferred Stock
2019-11-12
4
C
0
2000
D
Common Stock
395
0
D
Series C Preferred Stock
2019-11-12
4
C
0
6774
D
Common Stock
1339
0
D
Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis.
/s/ J. Mel Sorensen, Attorney-in-Fact
2019-11-12